← Back to Search

ABCp for Lower Back Pain

Phase 2
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Licensed physicians in the Edmonton West Primary Care Network (EWPCN) and the Calgary Chronic Pain Centre (CPC)
Age ≥18 years; (no upper age limit)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 30 months
Awards & highlights

Study Summary

This trial is testing whether a new approach to managing low back pain will decrease healthcare resource utilization and improve quality of life.

Who is the study for?
This trial is for family physicians in Alberta treating patients with lower back pain. Physicians must be over 18, speak English, and understand written information to consent. Patients with low back pain due to recent accidents or other clinical trials are excluded.Check my eligibility
What is being tested?
The study tests the Alberta Back Carepathway (ABCp) against usual care. ABCp trains physicians in guideline-based interventions for lower back pain at no extra cost, aiming to reduce healthcare resource use and improve quality of life.See study design
What are the potential side effects?
Since this trial involves training in care pathways rather than medication or invasive procedures, traditional side effects are not a concern. However, there may be indirect effects related to changes in patient management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
This criterion refers to doctors who are allowed to participate in the study from specific healthcare networks in Edmonton and Calgary.
Select...
You must be at least 18 years old with no maximum age limit.
Select...
You have cauda equina syndrome, infection, or a fracture.
Select...
You have had cancer in the past or are older in age.
Select...
You are over 70 years old, female, have had a significant injury, or have used corticosteroids for a long time.
Select...
For the CPC site, participants with a score of 3 or more on the first two questions or on the third and fourth questions of the PHQ4 depression and anxiety screening will not be included.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 30 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 30 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Primary Care visits
Secondary outcome measures
GP ordered LBP imaging
GP requested specialist consultations

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ABCpExperimental Treatment1 Intervention
The patient sees MD that follows ABCp, patient then enrolls in ABCp intervention based on MD's categorization of low back pain.
Group II: Usual CareActive Control1 Intervention
The patient receives "usual care" at the clinical site.

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
886 Previous Clinical Trials
384,538 Total Patients Enrolled
Canadian Chiropractic Research FoundationUNKNOWN
1 Previous Clinical Trials
25 Total Patients Enrolled
Bone and Joint Health SCNUNKNOWN

Media Library

Alberta Back Care Pathway (ABCp) Clinical Trial Eligibility Overview. Trial Name: NCT05452876 — Phase 2
Lower Back Pain Research Study Groups: ABCp, Usual Care
Lower Back Pain Clinical Trial 2023: Alberta Back Care Pathway (ABCp) Highlights & Side Effects. Trial Name: NCT05452876 — Phase 2
Alberta Back Care Pathway (ABCp) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05452876 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical research still recruiting participants?

"Per the clinicaltrials.gov website, recruitment for this medical trial is still open. It was initially published on March 31st 2021 and recently revised on July 7th 2022."

Answered by AI

How many individuals have taken part in this clinical investigation?

"Affirmative. According to the info hosted on clinicaltrials.gov, this research project is actively recruiting participants with its first post dated March 31st 2021 and most recent update from July 7th 2022. The study needs a total of 240 volunteers at one location for completion."

Answered by AI

Has ABCp been sanctioned by the Food and Drug Administration?

"Our team at Power evaluated ABCp's safety, assigning it a score of 2 based on the Phase 2 trial data suggesting some level of security but no evidence to back up efficacy."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
University of Alberta
What portion of applicants met pre-screening criteria?
Met criteria
~38 spots leftby Dec 2024